one and all FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Manufacturer Merck & Co., Inc. Drug Class Dopaminergic antiparkinsonism agents Related Drugs dopaminergic antiparkinsonism agents ropinirole , carbidopa , pramipexole , Sinemet , Requip , carbidopa / levodopa Parkinson's Disease Exelon , ropinirole , pramipexole , Sinemet , Requip , benztropine , carbidopa / levodopa , Mirapex , More... Neuroleptic Malignant Syndrome carbidopa , Sinemet , carbidopa / levodopa , Lodosyn , Parcopa , More... GTP-CH Deficiency carbidopa , Sinemet , carbidopa / levodopa , Lodosyn , Parcopa , More... Sinemet CR Rating 3 User Reviews 7.7 /10 3 User Reviews 7.7 Rate it! Sinemet CR Images Sinemet CR 50 mg / 200 mg (SINEMET CR 521) View all images is significant
photographs Sinemet CR in recent times
EmoticonEmoticon